Recombinant Human VEGF 121 (aa 207-327) Protein, CF 4644-VS-010/CF from R&D Systems, a Bio-Techne Brand

Product Specs
ItemRecombinant Human VEGF 121 (aa 207-327) Protein, CF
CompanyR&D Systems, a Bio-Techne Brand
Price $351.00Supplier Page View Company Product Page
Catalog Number4644-VS-010/CF
Size10 ug
ApplicationsBioactivity
FormatLyophilized from a 0.2 µm filtered solution in HCl
Purity>95%, by SDS-PAGE under reducing conditions and visualized by silver stain
Molecular Weight14 kDa
Conjugate/TagUnconjugated
SpeciesHuman
Molecule NameVEGF
Source/Expression SystemE. coli-derived Recombinant Human VEGF 121 (aa 207-327) Protein, CF
NCBI Full Gene Namevascular endothelial growth factor A
NCBI Gene AliasesMVCD1, VPF, VEGF
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

(1) Assessment of mouse VEGF neutralization by ranibizumab and afliberceptPloS oneJanuary 1, 2022Ichiyama Y, Matsumoto R, Obata S, Sawada O, Saishin Y, Kakinoki M, Sawada T, Ohji M.

(2) CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistanceCell reportsAugust 17, 2021Ma S, Mangala LS, Hu W, Bayaktar E, Yokoi A, Hu W, Pradeep S, Lee S, Piehowski PD, Villar-Prados A, et al.

(3) VEGF counteracts amyloid-β-induced synaptic dysfunctionCell reportsMay 11, 2021Martin L, Bouvet P, Chounlamountri N, Watrin C, Besançon R, Pinatel D, Meyronet D, Honnorat J, Buisson A, Salin PA, et al.

(6) Growth Factor-like Gene Regulation Is Separable from Survival and Maturation in Antibody-Secreting CellsJournal of immunology (Baltimore, Md. : 1950)February 15, 2019Stephenson S, Care MA, Fan I, Zougman A, Westhead DR, Doody GM, Tooze RM.

(8) Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using ¹¹¹In-bevacizumabEJNMMI researchDecember 1, 2017Patel N, Able S, Allen D, Fokas E, Cornelissen B, Gleeson FV, Harris AL, Vallis KA.

(9) Engineered ligand-based VEGFR antagonists with increased receptor binding affinity more effectively inhibit angiogenesisBioengineering & translational medicineMarch 1, 2017Kapur S, Silverman AP, Ye AZ, Papo N, Jindal D, Blumenkranz MS, Cochran JR.

(10) Fluorescent resonance energy transfer imaging of VEGFR dimerizationAnticancer researchMay 1, 2014Ahmadova Z, Yagublu V, Förg T, Hajiyeva Y, Jesenofsky R, Hafner M, Keese M.

(11) The docking protein FRS2α is a critical regulator of VEGF receptors signalingProceedings of the National Academy of Sciences of the United States of AmericaApril 15, 2014Chen PY, Qin L, Zhuang ZW, Tellides G, Lax I, Schlessinger J, Simons M.

(14) The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domainFASEB journal : official publication of the Federation of American Societies for Experimental BiologyDecember 1, 2010Martino MM, Hubbell JA.

(15) VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivoBritish journal of cancerOctober 6, 2009Rennel ES, Varey AH, Churchill AJ, Wheatley ER, Stewart L, Mather S, Bates DO, Harper SJ.

Recombinant Human VEGF 121 (aa 207-327) Protein, CF from R&D Systems, a Bio-Techne Brand